| Authors: |
Garon EB; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California. Electronic address: egaron@mednet.ucla.edu., Spira AI; Co-Director, Virginia Cancer Specialists Research Institute and NEXT Oncology, Fairfax, Virginia., Goldberg SB; Department of Internal Medicine, Yale Cancer Center, New Haven, Connecticut., Chaft JE; Department of Medicine, Weill Cornell Medical College and Memorial Sloan-Kettering Cancer Center, New York, New York., Papadimitrakopoulou V; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cascone T; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Antonia SJ; H. Lee Moffitt Cancer Center, Tampa, Florida., Brahmer JR; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Camidge DR; Department of Medicine-Medical Oncology, University of Colorado Cancer Center, Denver, Colorado., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Wozniak AJ; Department of Medicine, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania., Felip E; Deparmtent of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Wu S; Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland., Ascierto ML; Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland., Elgeioushi N; Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland., Awad MM; Dana-Farber Cancer Institute, Boston, Massachusetts. |
